Recent research has highlighted the involvement of PPARG in regulating lipid degeneration and promoting neutrophil infiltration in the liver during the transition from inflammatory liver disease and fatty liver to hepatocellular carcinoma (Chan et al., 2017; Wang et al., 2017). Here, PPARG is linked to hepatocellular carcinoma.